Thematic Review Series: Proteomics. An integrated omics analysis of eicosanoid biology

Aderem, 2005, Systems biology: its practice and challenges, Cell., 121, 511, 10.1016/j.cell.2005.04.020 de Godoy, 2008, Comprehensive mass-spectrometry-based proteome quantification of haploid versus diploid yeast, Nature, 455, 1251, 10.1038/nature07341 Funk, 2001, Prostaglandins and leukotrienes: advances in eicosanoid biology, Science., 294, 1871, 10.1126/science.294.5548.1871 Simmons, 2004, Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition, Pharmacol. Rev., 56, 387, 10.1124/pr.56.3.3 Smith, 2000, Cyclooxygenases: structural, cellular, and molecular biology, Annu. Rev. Biochem., 69, 145, 10.1146/annurev.biochem.69.1.145 Serhan, 2008, Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators, Nat. Rev. Immunol., 8, 349, 10.1038/nri2294 Feng, 2006 Schmelzer, 2007, The lipid maps initiative in lipidomics, Methods Enzymol., 432, 171, 10.1016/S0076-6879(07)32007-7 Buczynski, 2007, TLR-4 and sustained calcium agonists synergistically produce eicosanoids independent of protein synthesis in RAW264.7 cells, J. Biol. Chem., 282, 22834, 10.1074/jbc.M701831200 Domon, 2006, Mass spectrometry and protein analysis, Science., 312, 212, 10.1126/science.1124619 Bantscheff, 2007, Quantitative mass spectrometry in proteomics: a critical review, Anal. Bioanal. Chem., 389, 1017, 10.1007/s00216-007-1486-6 Keshishian, 2007, Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution, Mol. Cell. Proteomics., 6, 2212, 10.1074/mcp.M700354-MCP200 Schaloske, 2006, The phospholipase A2 superfamily and its group numbering system, Biochim. Biophys. Acta., 1761, 1246, 10.1016/j.bbalip.2006.07.011 Six, 2000, The expanding superfamily of phospholipase A(2) enzymes: classification and characterization, Biochim. Biophys. Acta., 1488, 1, 10.1016/S1388-1981(00)00105-0 Burke, 2008, Phospholipase A2 structure/function, mechanism and signaling, J. Lipid Res Uozumi, 2002, Roles for cytosolic phospholipase A2alpha as revealed by gene-targeted mice, Prostaglandins Other Lipid Mediat., 68–69, 59, 10.1016/S0090-6980(02)00021-7 Ghosh, 2006, Properties of the Group IV phospholipase A2 family, Prog. Lipid Res., 45, 487, 10.1016/j.plipres.2006.05.003 Bonventre, 1997, Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2, Nature., 390, 622, 10.1038/37635 Uozumi, 1997, Role of cytosolic phospholipase A2 in allergic response and parturition, Nature., 390, 618, 10.1038/37622 Adler, 2008, Inherited human cPLA(2alpha) deficiency is associated with impaired eicosanoid biosynthesis, small intestinal ulceration, and platelet dysfunction, J. Clin. Invest., 118, 2121 Lambeau, 2008, Biochemistry and physiology of mammalian secreted phospholipases A2, Annu. Rev. Biochem., 77, 495, 10.1146/annurev.biochem.76.062405.154007 Rouzer, 2008, Cyclooxygenases: structural and functional insights, J. Lipid Res Nelson, 1974, Prostaglandin nomenclature, J. Med. Chem., 17, 911, 10.1021/jm00255a001 Whittaker, 1976, The chemical structure of prostaglandin X (prostacyclin), Prostaglandins., 12, 915, 10.1016/0090-6980(76)90126-X Wu, 2005, Cellular and molecular biology of prostacyclin synthase, Biochem. Biophys. Res. Commun., 338, 45, 10.1016/j.bbrc.2005.08.021 Chiang, 2006, Crystal structure of the human prostacyclin synthase, J. Mol. Biol., 364, 266, 10.1016/j.jmb.2006.09.039 Hecker, 1989, On the mechanism of prostacyclin and thromboxane A2 biosynthesis, J. Biol. Chem., 264, 141, 10.1016/S0021-9258(17)31235-8 Katsuyama, 1994, Cloning and expression of a cDNA for the human prostacyclin receptor, FEBS Lett., 344, 74, 10.1016/0014-5793(94)00355-6 Boie, 1994, Cloning and expression of a cDNA for the human prostanoid IP receptor, J. Biol. Chem., 269, 12173, 10.1016/S0021-9258(17)32697-2 Aubert, 1996, Evidence for a novel regulatory pathway activated by (carba)prostacyclin in preadipose and adipose cells, FEBS Lett., 397, 117, 10.1016/S0014-5793(96)01152-0 Kojo, 2003, Evaluation of human peroxisome proliferator-activated receptor (PPAR) subtype selectivity of a variety of anti-inflammatory drugs based on a novel assay for PPAR delta(beta), J. Pharmacol. Sci., 93, 347, 10.1254/jphs.93.347 Hamberg, 1975, Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides, Proc. Natl. Acad. Sci. USA., 72, 2994, 10.1073/pnas.72.8.2994 Kinsella, 1997, The human thromboxane A2 receptor alpha isoform (TP alpha) functionally couples to the G proteins Gq and G11 in vivo and is activated by the isoprostane 8-epi prostaglandin F2 alpha, J. Pharmacol. Exp. Ther., 281, 957 Samuelsson, 1963, Isolation and identification of prostaglandins from human seminal plasma. 18. Prostaglandins and related factors, J. Biol. Chem., 238, 3229, 10.1016/S0021-9258(18)48651-6 Park, 2006, Prostaglandin E2 synthesis and secretion: the role of PGE2 synthases, Clin. Immunol., 119, 229, 10.1016/j.clim.2006.01.016 Tanioka, 2000, Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis, J. Biol. Chem., 275, 32775, 10.1074/jbc.M003504200 Murakami, 2002, Prostaglandin E synthase, Prostaglandins Other Lipid Mediat., 68–69, 383, 10.1016/S0090-6980(02)00043-6 Jakobsson, 1999, Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target, Proc. Natl. Acad. Sci. USA., 96, 7220, 10.1073/pnas.96.13.7220 Huang, 2006, Structural and functional characterization of human microsomal prostaglandin E synthase-1 by computational modeling and site-directed mutagenesis, Bioorg. Med. Chem., 14, 3553, 10.1016/j.bmc.2006.01.010 Samuelsson, 2007, Membrane prostaglandin E synthase-1: a novel therapeutic target, Pharmacol. Rev., 59, 207, 10.1124/pr.59.3.1 Watanabe, 1997, Two types of microsomal prostaglandin E synthase: glutathione-dependent and -independent prostaglandin E synthases, Biochem. Biophys. Res. Commun., 235, 148, 10.1006/bbrc.1997.6708 Tanikawa, 2002, Identification and characterization of a novel type of membrane-associated prostaglandin E synthase, Biochem. Biophys. Res. Commun., 291, 884, 10.1006/bbrc.2002.6531 Yamada, 2005, Crystal structure and possible catalytic mechanism of microsomal prostaglandin E synthase type 2 (mPGES-2), J. Mol. Biol., 348, 1163, 10.1016/j.jmb.2005.03.035 Ito, 1989, Prostaglandin D2: a biochemical perspective, Prostaglandins Leukot. Essent. Fatty Acids., 37, 219, 10.1016/0952-3278(89)90033-1 Abdel-Halim, 1977, Identification of prostaglandin D2 as a major prostaglandin in homogenates of rat brain, Prostaglandins., 14, 633, 10.1016/0090-6980(77)90190-3 Roberts, 1979, Prostaglandin thromboxane, and 12-hydroxy-5,8,10,14-eicosatetraenoic acid production by ionophore-stimulated rat serosal mast cells, Biochim. Biophys. Acta., 575, 185, 10.1016/0005-2760(79)90020-1 Urade, 1995, Structural and functional significance of cysteine residues of glutathione-independent prostaglandin D synthase. Identification of Cys65 as an essential thiol, J. Biol. Chem., 270, 1422, 10.1074/jbc.270.3.1422 Shimamoto, 2007, NMR solution structure of lipocalin-type prostaglandin D synthase: evidence for partial overlapping of catalytic pocket and retinoic acid-binding pocket within the central cavity, J. Biol. Chem., 282, 31373, 10.1074/jbc.M700123200 Kanaoka, 1997, Cloning and crystal structure of hematopoietic prostaglandin D synthase, Cell., 90, 1085, 10.1016/S0092-8674(00)80374-8 Pettipher, 2008, The roles of the prostaglandin D(2) receptors DP(1) and CRTH2 in promoting allergic responses, Br. J. Pharmacol., 153, S191, 10.1038/sj.bjp.0707488 Sawyer, 2002, Molecular pharmacology of the human prostaglandin D2 receptor, CRTH2, Br. J. Pharmacol., 137, 1163, 10.1038/sj.bjp.0704973 Basu, 2007, Novel cyclooxygenase-catalyzed bioactive prostaglandin F2alpha from physiology to new principles in inflammation, Med. Res. Rev., 27, 435, 10.1002/med.20098 Abramovitz, 1994, Cloning and expression of a cDNA for the human prostanoid FP receptor, J. Biol. Chem., 269, 2632, 10.1016/S0021-9258(17)41991-0 Daiyasu, 2008, Recruitment of thioredoxin-like domains into prostaglandin synthases, Biochem. Biophys. Res. Commun., 369, 281, 10.1016/j.bbrc.2008.02.088 Suzuki-Yamamoto, 1999, cDNA cloning, expression and characterization of human prostaglandin F synthase, FEBS Lett., 462, 335, 10.1016/S0014-5793(99)01551-3 Moriuchi, 2008, Molecular characterization of a novel type of prostamide/prostaglandin F synthase, belonging to the thioredoxin-like superfamily, J. Biol. Chem., 283, 792, 10.1074/jbc.M705638200 Komoto, 2004, Crystal structure of human prostaglandin F synthase (AKR1C3), Biochemistry., 43, 2188, 10.1021/bi036046x Komoto, 2006, Prostaglandin F2alpha formation from prostaglandin H2 by prostaglandin F synthase (PGFS): crystal structure of PGFS containing bimatoprost, Biochemistry., 45, 1987, 10.1021/bi051861t Penning, 2006, Aldo-keto reductase (AKR) 1C3: role in prostate disease and the development of specific inhibitors, Mol. Cell. Endocrinol., 248, 182, 10.1016/j.mce.2005.12.009 Levine, 1975, Stereospecificity of enzymatic reduction of prostaglandin E2 to F2alpha, Prostaglandins., 9, 531, 10.1016/0090-6980(75)90059-3 Asselin, 2000, Detection and regulation of the messenger for a putative bovine endometrial 9-keto-prostaglandin E(2) reductase: effect of oxytocin and interferon-tau, Biol. Reprod., 62, 125, 10.1095/biolreprod62.1.125 Wermuth, 1981, Purification and properties of an NADPH-dependent carbonyl reductase from human brain. Relationship to prostaglandin 9-ketoreductase and xenobiotic ketone reductase, J. Biol. Chem., 256, 1206, 10.1016/S0021-9258(19)69950-3 Miura, 2008, Different functions between human monomeric carbonyl reductase 3 and carbonyl reductase 1, Mol. Cell Biochem., 315, 113, 10.1007/s11010-008-9794-5 Yokoyama, 2007, Clofibric acid, a peroxisome proliferator-activated receptor alpha ligand, inhibits growth of human ovarian cancer, Mol. Cancer Ther., 6, 1379, 10.1158/1535-7163.MCT-06-0722 Waclawik, 2007, Differential expression of prostaglandin (PG) synthesis enzymes in conceptus during peri-implantation period and endometrial expression of carbonyl reductase/PG 9-ketoreductase in the pig, J. Endocrinol., 194, 499, 10.1677/JOE-07-0155 Straus, 2001, Cyclopentenone prostaglandins: new insights on biological activities and cellular targets, Med. Res. Rev., 21, 185, 10.1002/med.1006 Powell, 2003, 15-Deoxy-delta12,14–PGJ2: endogenous PPARgamma ligand or minor eicosanoid degradation product?, J. Clin. Invest., 112, 828, 10.1172/JCI19796 Murphy, 1979, Leukotriene C: a slow-reacting substance from murine mastocytoma cells, Proc. Natl. Acad. Sci. USA., 76, 4275, 10.1073/pnas.76.9.4275 Matsumoto, 1988, Molecular cloning and amino acid sequence of human 5-lipoxygenase, Proc. Natl. Acad. Sci. USA., 85, 26, 10.1073/pnas.85.1.26 Ferguson, 2007, Crystal structure of inhibitor-bound human 5-lipoxygenase-activating protein, Science., 317, 510, 10.1126/science.1144346 Murphy, 2007, Biosynthesis and metabolism of leukotrienes, Biochem. J., 405, 379, 10.1042/BJ20070289 Powell, 2005, Biochemistry, biology and chemistry of the 5-lipoxygenase product 5-oxo-ETE, Prog. Lipid Res., 44, 154, 10.1016/j.plipres.2005.04.002 Jones, 2003, Expression and characterization of a 5-oxo-6E,8Z,11Z,14Z-eicosatetraenoic acid receptor highly expressed on human eosinophils and neutrophils, Mol. Pharmacol., 63, 471, 10.1124/mol.63.3.471 Borgeat, 1979, Metabolism of arachidonic acid in polymorphonuclear leukocytes. Structural analysis of novel hydroxylated compounds, J. Biol. Chem., 254, 7865, 10.1016/S0021-9258(18)36026-5 Ford-Hutchinson, 1980, Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes, Nature., 286, 264, 10.1038/286264a0 Tager, 2003, BLT1 and BLT2: the leukotriene B(4) receptors, Prostaglandins Leukot. Essent. Fatty Acids., 69, 123, 10.1016/S0952-3278(03)00073-5 Tager, 2000, BLTR mediates leukotriene B(4)-induced chemotaxis and adhesion and plays a dominant role in eosinophil accumulation in a murine model of peritonitis, J. Exp. Med., 192, 439, 10.1084/jem.192.3.439 Haribabu, 2000, Targeted disruption of the leukotriene B(4) receptor in mice reveals its role in inflammation and platelet-activating factor-induced anaphylaxis, J. Exp. Med., 192, 433, 10.1084/jem.192.3.433 Okuno, 2008, 12(S)-Hydroxyheptadeca-5Z, 8E, 10E-trienoic acid is a natural ligand for leukotriene B4 receptor 2, J. Exp. Med., 205, 759, 10.1084/jem.20072329 Haeggstrom, 2004, Leukotriene A4 hydrolase/aminopeptidase, the gatekeeper of chemotactic leukotriene B4 biosynthesis, J. Biol. Chem., 279, 50639, 10.1074/jbc.R400027200 Tholander, 2005, Leukotriene A4 hydrolase, insights into the molecular evolution by homology modeling and mutational analysis of enzyme from Saccharomyces cerevisiae, J. Biol. Chem., 280, 33477, 10.1074/jbc.M506821200 Fitzpatrick, 1983, Metabolism of leukotriene A4 by an enzyme in blood plasma: a possible leukotactic mechanism, Proc. Natl. Acad. Sci. USA., 80, 5425, 10.1073/pnas.80.17.5425 Funk, 1987, Molecular cloning and amino acid sequence of leukotriene A4 hydrolase, Proc. Natl. Acad. Sci. USA., 84, 6677, 10.1073/pnas.84.19.6677 Thunnissen, 2001, Crystal structure of human leukotriene A(4) hydrolase, a bifunctional enzyme in inflammation, Nat. Struct. Biol., 8, 131, 10.1038/84117 Peters-Golden, 2006, Cysteinyl leukotrienes: multi-functional mediators in allergic rhinitis, Clin. Exp. Allergy., 36, 689, 10.1111/j.1365-2222.2006.02498.x Rovati, 2007, Cysteinyl-leukotriene receptors and cellular signals, ScientificWorldJournal., 7, 1375, 10.1100/tsw.2007.185 Lam, 1994, Expression cloning of a cDNA for human leukotriene C4 synthase, an integral membrane protein conjugating reduced glutathione to leukotriene A4, Proc. Natl. Acad. Sci. USA., 91, 7663, 10.1073/pnas.91.16.7663 Welsch, 1994, Molecular cloning and expression of human leukotriene-C4 synthase, Proc. Natl. Acad. Sci. USA., 91, 9745, 10.1073/pnas.91.21.9745 Scoggan, 1997, Production of leukotriene C4 in different human tissues is attributable to distinct membrane bound biosynthetic enzymes, J. Biol. Chem., 272, 10182, 10.1074/jbc.272.15.10182 Kanaoka, 2001, Attenuated zymosan-induced peritoneal vascular permeability and IgE-dependent passive cutaneous anaphylaxis in mice lacking leukotriene C4 synthase, J. Biol. Chem., 276, 22608, 10.1074/jbc.M103562200 Ago, 2007, Crystal structure of a human membrane protein involved in cysteinyl leukotriene biosynthesis, Nature., 448, 609, 10.1038/nature05936 Martinez Molina, 2007, Structural basis for synthesis of inflammatory mediators by human leukotriene C4 synthase, Nature., 448, 613, 10.1038/nature06009 Anderson, 1982, Interconversion of leukotrienes catalyzed by purified gamma-glutamyl transpeptidase: concomitant formation of leukotriene D4 and gamma-glutamyl amino acids, Proc. Natl. Acad. Sci. USA., 79, 1088, 10.1073/pnas.79.4.1088 Keillor, 2005, Gamma-glutamyl transpeptidase substrate specificity and catalytic mechanism, Methods Enzymol., 401, 449, 10.1016/S0076-6879(05)01027-X Carter, 1997, Metabolism of leukotriene C4 in gamma-glutamyl transpeptidase-deficient mice, J. Biol. Chem., 272, 12305, 10.1074/jbc.272.19.12305 Heisterkamp, 1991, Identification of a human gamma-glutamyl cleaving enzyme related to, but distinct from, gamma-glutamyl transpeptidase, Proc. Natl. Acad. Sci. USA., 88, 6303, 10.1073/pnas.88.14.6303 Carter, 1998, Gamma-glutamyl leukotrienase, a gamma-glutamyl transpeptidase gene family member, is expressed primarily in spleen, J. Biol. Chem., 273, 28277, 10.1074/jbc.273.43.28277 Shi, 2001, Disruption of gamma-glutamyl leukotrienase results in disruption of leukotriene D(4) synthesis in vivo and attenuation of the acute inflammatory response, Mol. Cell. Biol., 21, 5389, 10.1128/MCB.21.16.5389-5395.2001 Adachi, 1989, Purification and characterization of human microsomal dipeptidase, J. Biochem., 105, 957, 10.1093/oxfordjournals.jbchem.a122787 Habib, 1998, Leukotriene D4 and cystinyl-bis-glycine metabolism in membrane-bound dipeptidase-deficient mice, Proc. Natl. Acad. Sci. USA., 95, 4859, 10.1073/pnas.95.9.4859 Habib, 2003, Identification of two additional members of the membrane-bound dipeptidase family, FASEB J., 17, 1313, 10.1096/fj.02-0899fje Kuhn, 2006, Inflammation and immune regulation by 12/15-lipoxygenases, Prog. Lipid Res., 45, 334, 10.1016/j.plipres.2006.02.003 Minor, 1996, Crystal structure of soybean lipoxygenase L-1 at 1.4 A resolution, Biochemistry., 35, 10687, 10.1021/bi960576u Skrzypczak-Jankun, 1997, Structure of soybean lipoxygenase L3 and a comparison with its L1 isoenzyme, Proteins., 29, 15, 10.1002/(SICI)1097-0134(199709)29:1<15::AID-PROT2>3.0.CO;2-E Gillmor, 1997, The structure of mammalian 15-lipoxygenase reveals similarity to the lipases and the determinants of substrate specificity, Nat. Struct. Biol., 4, 1003, 10.1038/nsb1297-1003 Coffa, 2005, A comprehensive model of positional and stereo control in lipoxygenases, Biochem. Biophys. Res. Commun., 338, 87, 10.1016/j.bbrc.2005.07.185 Murakami, 1999, Evidence for direct binding of fatty acids and eicosanoids to human peroxisome proliferators-activated receptor alpha, Biochem. Biophys. Res. Commun., 260, 609, 10.1006/bbrc.1999.0951 Huang, 1999, Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase, Nature., 400, 378, 10.1038/22572 Hsi, 2002, Opposing effects of 15-lipoxygenase-1 and -2 metabolites on MAPK signaling in prostate. Alteration in peroxisome proliferator-activated receptor gamma, J. Biol. Chem., 277, 40549, 10.1074/jbc.M203522200 Wen, 2008, Role of 12/15-lipoxygenase in the expression of MCP-1 in mouse macrophages, Am. J. Physiol. Heart Circ. Physiol., 294, H1933, 10.1152/ajpheart.00260.2007 Zhang, 2005, 15(S)-hydroxyeicosatetraenoic acid induces angiogenesis via activation of PI3K-Akt-mTOR-S6K1 signaling, Cancer Res., 65, 7283, 10.1158/0008-5472.CAN-05-0633 Nie, 2006, Mechanisms regulating tumor angiogenesis by 12-lipoxygenase in prostate cancer cells, J. Biol. Chem., 281, 18601, 10.1074/jbc.M601887200 Kumar, 2009, Effects of (15S)-hydroperoxyeicosatetraenoic acid and (15S)-hydroxyeicosatetraenoic acid on the acute- lymphoblastic-leukaemia cell line Jurkat: activation of the Fas-mediated death pathway, Biotechnol. Appl. Biochem., 52, 121, 10.1042/BA20070264 Kwon, 2005, Arachidonic acid induces neuronal death through lipoxygenase and cytochrome P450 rather than cyclooxygenase, J. Neurosci. Res., 81, 73, 10.1002/jnr.20520 Hwang, 2000, Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances, Proc. Natl. Acad. Sci. USA., 97, 6155, 10.1073/pnas.97.11.6155 Nigam, 2007, Structure, biochemistry and biology of hepoxilins: an update, FEBS J., 274, 3503, 10.1111/j.1742-4658.2007.05910.x Pace-Asciak, 1983, Arachidonic acid epoxides. Isolation and structure of two hydroxy epoxide intermediates in the formation of 8,11,12- and 10,11,12-trihydroxyeicosatrienoic acids, J. Biol. Chem., 258, 6835, 10.1016/S0021-9258(18)32298-1 Pace-Asciak, 1989, Purification of hepoxilin epoxide hydrolase from rat liver, J. Biol. Chem., 264, 9310, 10.1016/S0021-9258(18)60532-0 Dho, 1990, Hepoxilin A3 induces changes in cytosolic calcium, intracellular pH and membrane potential in human neutrophils, Biochem. J., 266, 63, 10.1042/bj2660063 Mrsny, 2004, Identification of hepoxilin A3 in inflammatory events: a required role in neutrophil migration across intestinal epithelia, Proc. Natl. Acad. Sci. USA., 101, 7421, 10.1073/pnas.0400832101 Pace-Asciak, 1986, Hepoxilins, potential endogenous mediators of insulin release, Prog. Lipid Res., 25, 625, 10.1016/0163-7827(86)90127-X Nigam, 2008, Hepoxilin A3 (HXA3) synthase deficiency is causative of a novel ichthyosis form, FEBS Lett., 582, 279, 10.1016/j.febslet.2007.12.017 Carlen, 1994, Formation and electrophysiological actions of the arachidonic acid metabolites, hepoxilins, at nanomolar concentrations in rat hippocampal slices, Neuroscience., 58, 493, 10.1016/0306-4522(94)90075-2 Reynaud, 1996, Hepoxilin A3-specific binding in human neutrophils, Biochem. J., 313, 537, 10.1042/bj3130537 Serhan, 1984, Lipoxins: novel series of biologically active compounds formed from arachidonic acid in human leukocytes, Proc. Natl. Acad. Sci. USA., 81, 5335, 10.1073/pnas.81.17.5335 Serhan, 2005, Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution, Prostaglandins Leukot. Essent. Fatty Acids., 73, 141, 10.1016/j.plefa.2005.05.002 Serhan, 1990, Lipoxin formation during human neutrophil-platelet interactions. Evidence for the transformation of leukotriene A4 by platelet 12-lipoxygenase in vitro, J. Clin. Invest., 85, 772, 10.1172/JCI114503 Claria, 1995, Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions, Proc. Natl. Acad. Sci. USA., 92, 9475, 10.1073/pnas.92.21.9475 Chiang, 2006, The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo, Pharmacol. Rev., 58, 463, 10.1124/pr.58.3.4 Gronert, 2001, Selectivity of recombinant human leukotriene D(4), leukotriene B(4), and lipoxin A(4) receptors with aspirin-triggered 15-epi-LXA(4) and regulation of vascular and inflammatory responses, Am. J. Pathol., 158, 3, 10.1016/S0002-9440(10)63937-5 Schaldach, 1999, Lipoxin A4: a new class of ligand for the Ah receptor, Biochemistry., 38, 7594, 10.1021/bi982861e Machado, 2006, Anti-inflammatory actions of lipoxin A4 and aspirin-triggered lipoxin are SOCS-2 dependent, Nat. Med., 12, 330, 10.1038/nm1355 Yokoyama, 1986, Arachidonate 12-lipoxygenase purified from porcine leukocytes by immunoaffinity chromatography and its reactivity with hydroperoxyeicosatetraenoic acids, J. Biol. Chem., 261, 16714, 10.1016/S0021-9258(18)66623-2 Feltenmark, 2008, Eoxins are proinflammatory arachidonic acid metabolites produced via the 15-lipoxygenase-1 pathway in human eosinophils and mast cells, Proc. Natl. Acad. Sci. USA., 105, 680, 10.1073/pnas.0710127105 Drazen, 1981, Contractile activities of structural analogs of leukotrienes C and D: necessity of a hydrophobic region, Proc. Natl. Acad. Sci. USA., 78, 3195, 10.1073/pnas.78.5.3195 Sala, 1990, Contractile and binding activities of structural analogues of LTC4 in the longitudinal muscle of guinea-pig ileum, Eicosanoids., 3, 105 Burger, 2000, Positional- and stereo-selectivity of fatty acid oxygenation catalysed by mouse (12S)-lipoxygenase isoenzymes, Biochem. J., 348, 329, 10.1042/bj3480329 Schweiger, 2007, Inducible expression of 15-lipoxygenase-2 and 8-lipoxygenase inhibits cell growth via common signaling pathways, J. Lipid Res., 48, 553, 10.1194/jlr.M600311-JLR200 Hamberg, 1974, Prostaglandin endoperoxides. Novel transformations of arachidonic acid in human platelets, Proc. Natl. Acad. Sci. USA., 71, 3400, 10.1073/pnas.71.9.3400 Funk, 1990, Molecular cloning, primary structure, and expression of the human platelet/erythroleukemia cell 12-lipoxygenase, Proc. Natl. Acad. Sci. USA., 87, 5638, 10.1073/pnas.87.15.5638 Izumi, 1990, Cloning of the cDNA for human 12-lipoxygenase, Proc. Natl. Acad. Sci. USA., 87, 7477, 10.1073/pnas.87.19.7477 Virmani, 2001, Role of ‘platelet-type’ 12-lipoxygenase in skin carcinogenesis, Cancer Lett., 162, 161, 10.1016/S0304-3835(00)00634-0 Pidgeon, 2003, Overexpression of platelet-type 12-lipoxygenase promotes tumor cell survival by enhancing alpha(v)beta(3) and alpha(v)beta(5) integrin expression, Cancer Res., 63, 4258 Raso, 2004, Molecular identification, localization and function of platelet-type 12-lipoxygenase in human melanoma progression, under experimental and clinical conditions, Melanoma Res., 14, 245, 10.1097/01.cmr.0000138479.00897.d8 Chen, 1993, Structure-function properties of human platelet 12-lipoxygenase: chimeric enzyme and in vitro mutagenesis studies, FASEB J., 7, 694, 10.1096/fasebj.7.8.8500694 Sloane, 1995, Conversion of human 15-lipoxygenase to an efficient 12-lipoxygenase: the side-chain geometry of amino acids 417 and 418 determine positional specificity, Protein Eng., 8, 275, 10.1093/protein/8.3.275 Borngraber, 1999, Shape and specificity in mammalian 15-lipoxygenase active site. The functional interplay of sequence determinants for the reaction specificity, J. Biol. Chem., 274, 37345, 10.1074/jbc.274.52.37345 Nigam, 2004, The rat leukocyte-type 12-lipoxygenase exhibits an intrinsic hepoxilin A3 synthase activity, J. Biol. Chem., 279, 29023, 10.1074/jbc.M307576200 Romano, 1993, Lipoxin synthase activity of human platelet 12-lipoxygenase, Biochem. J., 296, 127, 10.1042/bj2960127 Funk, 1996, Functional expression and cellular localization of a mouse epidermal lipoxygenase, J. Biol. Chem., 271, 23338, 10.1074/jbc.271.38.23338 Kinzig, 1997, Murine epidermal lipoxygenase (Aloxe) encodes a 12-lipoxygenase isoform, FEBS Lett., 402, 162, 10.1016/S0014-5793(96)01517-7 Sun, 1998, Cloning of a human “epidermal-type” 12-lipoxygenase-related gene and chromosomal localization to 17p13, Cytogenet. Cell Genet., 81, 79, 10.1159/000014993 Hammarstrom, 1975, Increased concentrations of nonesterified arachidonic acid, 12L-hydroxy-5,8,10,14-eicosatetraenoic acid, prostaglandin E2, and prostaglandin F2alpha in epidermis of psoriasis, Proc. Natl. Acad. Sci. USA., 72, 5130, 10.1073/pnas.72.12.5130 Woollard, 1986, Stereochemical difference between 12-hydroxy-5,8,10,14-eicosatetraenoic acid in platelets and psoriatic lesions, Biochem. Biophys. Res. Commun., 136, 169, 10.1016/0006-291X(86)90891-0 Boeglin, 1998, A 12R-lipoxygenase in human skin: mechanistic evidence, molecular cloning, and expression, Proc. Natl. Acad. Sci. USA., 95, 6744, 10.1073/pnas.95.12.6744 Coffa, 2004, A single active site residue directs oxygenation stereospecificity in lipoxygenases: stereocontrol is linked to the position of oxygenation, Proc. Natl. Acad. Sci. USA., 101, 15579, 10.1073/pnas.0406727101 Meruvu, 2005, Sequence determinants for the reaction specificity of murine (12R)-lipoxygenase: targeted substrate modification and site-directed mutagenesis, J. Biol. Chem., 280, 36633, 10.1074/jbc.M508260200 Kinzig, 1999, cDNA cloning, genomic structure, and chromosomal localization of a novel murine epidermis-type lipoxygenase, Genomics., 58, 158, 10.1006/geno.1999.5816 Krieg, 2001, A gene cluster encoding human epidermis-type lipoxygenases at chromosome 17p13.1: cloning, physical mapping, and expression, Genomics., 73, 323, 10.1006/geno.2001.6519 Jobard, 2002, Lipoxygenase-3 (ALOXE3) and 12(R)-lipoxygenase (ALOX12B) are mutated in non-bullous congenital ichthyosiform erythroderma (NCIE) linked to chromosome 17p13.1, Hum. Mol. Genet., 11, 107, 10.1093/hmg/11.1.107 Yu, 2003, The lipoxygenase gene ALOXE3 implicated in skin differentiation encodes a hydroperoxide isomerase, Proc. Natl. Acad. Sci. USA., 100, 9162, 10.1073/pnas.1633612100 Sigal, 1988, Molecular cloning and primary structure of human 15-lipoxygenase, Biochem. Biophys. Res. Commun., 157, 457, 10.1016/S0006-291X(88)80271-7 Fleming, 1989, The complete sequence of the rabbit erythroid cell-specific 15-lipoxygenase mRNA: comparison of the predicted amino acid sequence of the erythrocyte lipoxygenase with other lipoxygenases, Gene., 79, 181, 10.1016/0378-1119(89)90103-0 Watanabe, 1993, Molecular cloning of a 12-lipoxygenase cDNA from rat brain, Eur. J. Biochem., 212, 605, 10.1111/j.1432-1033.1993.tb17699.x Chen, 1994, cDNA cloning, expression, mutagenesis of C-terminal isoleucine, genomic structure, and chromosomal localizations of murine 12-lipoxygenases, J. Biol. Chem., 269, 13979, 10.1016/S0021-9258(17)36743-1 Bryant, 1985, Leukotriene formation by a purified reticulocyte lipoxygenase enzyme. Conversion of arachidonic acid and 15-hydroperoxyeicosatetraenoic acid to 14, 15-leukotriene A4, J. Biol. Chem., 260, 3548, 10.1016/S0021-9258(19)83657-8 Sailesh, 1994, Sheep uterus dual lipoxygenase in the synthesis of 14,15-leukotrienes, Arch. Biochem. Biophys., 315, 362, 10.1006/abbi.1994.1512 Sigal, 1990, Expression of cloned human reticulocyte 15-lipoxygenase and immunological evidence that 15-lipoxygenases of different cell types are related, J. Biol. Chem., 265, 5113, 10.1016/S0021-9258(19)34092-X Glass, 2001, Atherosclerosis. the road ahead, Cell., 104, 503, 10.1016/S0092-8674(01)00238-0 Harkewicz, 2008, Cholesteryl ester hydroperoxides are biologically active components of minimally oxidized low density lipoprotein, J. Biol. Chem., 283, 10241, 10.1074/jbc.M709006200 Merched, 2008, Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators, FASEB J., 22, 3595, 10.1096/fj.08-112201 Brash, 1997, Discovery of a second 15S-lipoxygenase in humans, Proc. Natl. Acad. Sci. USA., 94, 6148, 10.1073/pnas.94.12.6148 Jisaka, 1997, Molecular cloning and functional expression of a phorbol ester-inducible 8S-lipoxygenase from mouse skin, J. Biol. Chem., 272, 24410, 10.1074/jbc.272.39.24410 Jisaka, 2000, Identification of amino acid determinants of the positional specificity of mouse 8S-lipoxygenase and human 15S-lipoxygenase-2, J. Biol. Chem., 275, 1287, 10.1074/jbc.275.2.1287 Jisaka, 2005, Double dioxygenation by mouse 8S-lipoxygenase: specific formation of a potent peroxisome proliferator-activated receptor alpha agonist, Biochem. Biophys. Res. Commun., 338, 136, 10.1016/j.bbrc.2005.08.029 Nelson, 2006, Cytochrome P450 nomenclature, 2004, Methods Mol. Biol., 320, 1 Roman, 2002, P-450 metabolites of arachidonic acid in the control of cardiovascular function, Physiol. Rev., 82, 131, 10.1152/physrev.00021.2001 Omura, 1999, Forty years of cytochrome P450, Biochem. Biophys. Res. Commun., 266, 690, 10.1006/bbrc.1999.1887 Schlichting, 2000, The catalytic pathway of cytochrome p450cam at atomic resolution, Science., 287, 1615, 10.1126/science.287.5458.1615 Hirao, 2005, Two states and two more in the mechanisms of hydroxylation and epoxidation by cytochrome P450, J. Am. Chem. Soc., 127, 13007, 10.1021/ja053847+ Nelson, 1999, Cytochrome P450 and the individuality of species, Arch. Biochem. Biophys., 369, 1, 10.1006/abbi.1999.1352 Nelson, 2004, Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants, Pharmacogenetics., 14, 1, 10.1097/00008571-200401000-00001 Ramarao, 1995, Substitution at residue 473 confers progesterone 21-hydroxylase activity to cytochrome P450 2C2, Mol. Pharmacol., 48, 417 Fleming, 2005, Cytochrome P-450 under pressure: more evidence for a link between 20-hydroxyeicosatetraenoic acid and hypertension, Circulation., 111, 5, 10.1161/01.CIR.0000152695.11867.D8 Ma, 1993, 20-Hydroxyeicosatetraenoic acid is an endogenous vasoconstrictor of canine renal arcuate arteries, Circ. Res., 72, 126, 10.1161/01.RES.72.1.126 Croft, 2000, Angiotensin II releases 20-HETE from rat renal microvessels, Am. J. Physiol. Renal Physiol., 279, F544, 10.1152/ajprenal.2000.279.3.F544 Schwartzman, 1985, Renal cytochrome P450-related arachidonate metabolite inhibits (Na+ + K+)ATPase, Nature., 314, 620, 10.1038/314620a0 Carroll, 1996, Cytochrome P-450-dependent HETEs: profile of biological activity and stimulation by vasoactive peptides, Am. J. Physiol., 271, R863 Bednar, 2000, 16(R)-hydroxyeicosatetraenoic acid, a novel cytochrome P450 product of arachidonic acid, suppresses activation of human polymorphonuclear leukocyte and reduces intracranial pressure in a rabbit model of thromboembolic stroke, Neurosurgery., 47, 1410, 10.1097/00006123-200012000-00029 Spector, 2008, Arachidonic acid cytochrome P450 epoxygenase pathway, J. Lipid Res Node, 1999, Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids, Science., 285, 1276, 10.1126/science.285.5431.1276 Liu, 2005, The antiinflammatory effect of laminar flow: the role of PPARgamma, epoxyeicosatrienoic acids, and soluble epoxide hydrolase, Proc. Natl. Acad. Sci. USA., 102, 16747, 10.1073/pnas.0508081102 Wong, 1997, Post-receptor signal transduction and regulation of 14(R),15(S)-epoxyeicosatrienoic acid (14,15-EET) binding in U-937 cells, J. Lipid Mediat. Cell Signal., 16, 155, 10.1016/S0929-7855(97)00005-9 Yang, 2008, Characterization of epoxyeicosatrienoic acid binding site in U937 membranes using a novel radiolabeled agonist, 20–125i-14,15-epoxyeicosa-8(Z)-enoic acid, J. Pharmacol. Exp. Ther., 324, 1019, 10.1124/jpet.107.129577 Node, 2001, Activation of Galpha s mediates induction of tissue-type plasminogen activator gene transcription by epoxyeicosatrienoic acids, J. Biol. Chem., 276, 15983, 10.1074/jbc.M100439200 Li, 1997, Epoxyeicosatrienoic acids activate K+ channels in coronary smooth muscle through a guanine nucleotide binding protein, Circ. Res., 80, 877, 10.1161/01.RES.80.6.877 Falck, 2003, 11,12-epoxyeicosatrienoic acid (11,12-EET): structural determinants for inhibition of TNF-alpha-induced VCAM-1 expression, Bioorg. Med. Chem. Lett., 13, 4011, 10.1016/j.bmcl.2003.08.060 Gauthier, 2004, 14,15-EET analogs: characterization of structural requirements for agonist and antagonist activity in bovine coronary arteries, Pharmacol. Res., 49, 515, 10.1016/j.phrs.2003.09.014 Watanabe, 2003, Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels, Nature., 424, 434, 10.1038/nature01807 Alessandri-Haber, 2006, A transient receptor potential vanilloid 4-dependent mechanism of hyperalgesia is engaged by concerted action of inflammatory mediators, J. Neurosci., 26, 3864, 10.1523/JNEUROSCI.5385-05.2006 Alessandri-Haber, 2008, Interaction of transient receptor potential vanilloid 4, integrin, and SRC tyrosine kinase in mechanical hyperalgesia, J. Neurosci., 28, 1046, 10.1523/JNEUROSCI.4497-07.2008 Sipe, 2008, Transient receptor potential vanilloid 4 mediates protease activated receptor 2-induced sensitization of colonic afferent nerves and visceral hyperalgesia, Am. J. Physiol. Gastrointest. Liver Physiol., 294, G1288, 10.1152/ajpgi.00002.2008 Earley, 2005, TRPV4 forms a novel Ca2+ signaling complex with ryanodine receptors and BKCa channels, Circ. Res., 97, 1270, 10.1161/01.RES.0000194321.60300.d6 Inceoglu, 2007, Soluble epoxide hydrolase inhibition reveals novel biological functions of epoxyeicosatrienoic acids (EETs), Prostaglandins Other Lipid Mediat., 82, 42, 10.1016/j.prostaglandins.2006.05.004 Lu, 2001, Activation of ATP-sensitive K(+) channels by epoxyeicosatrienoic acids in rat cardiac ventricular myocytes, J. Physiol., 537, 811, 10.1113/jphysiol.2001.012896 Ng, 2007, Cytochrome P450 eicosanoids are activators of peroxisome proliferator-activated receptor alpha, Drug Metab. Dispos., 35, 1126, 10.1124/dmd.106.013839 Kotlikoff, 2005, EDHF redux: EETs, TRPV4, and Ca2+ sparks, Circ. Res., 97, 1209, 10.1161/01.RES.0000196741.99904.e4 Spector, 2007, Action of epoxyeicosatrienoic acids on cellular function, Am. J. Physiol. Cell Physiol., 292, C996, 10.1152/ajpcell.00402.2006 Beetham, 1993, cDNA cloning and expression of a soluble epoxide hydrolase from human liver, Arch. Biochem. Biophys., 305, 197, 10.1006/abbi.1993.1411 Gomez, 2004, Structure of human epoxide hydrolase reveals mechanistic inferences on bifunctional catalysis in epoxide and phosphate ester hydrolysis, Biochemistry., 43, 4716, 10.1021/bi036189j Argiriadi, 1999, Detoxification of environmental mutagens and carcinogens: structure, mechanism, and evolution of liver epoxide hydrolase, Proc. Natl. Acad. Sci. USA., 96, 10637, 10.1073/pnas.96.19.10637 Morisseau, 2005, Epoxide hydrolases: mechanisms, inhibitor designs, and biological roles, Annu. Rev. Pharmacol. Toxicol., 45, 311, 10.1146/annurev.pharmtox.45.120403.095920 Draper, 1999, Inhibition of soluble and microsomal epoxide hydrolase by zinc and other metals, Toxicol. Sci., 52, 26, 10.1093/toxsci/52.1.26 Lu, 2001, Dihydroxyeicosatrienoic acids are potent activators of Ca(2+)-activated K(+) channels in isolated rat coronary arterial myocytes, J. Physiol., 534, 651, 10.1111/j.1469-7793.2001.t01-1-00651.x Fang, 2006, 14,15-Dihydroxyeicosatrienoic acid activates peroxisome proliferator-activated receptor-alpha, Am. J. Physiol. Heart Circ. Physiol., 290, H55, 10.1152/ajpheart.00427.2005 Milne, 2008, Human biochemistry of the isoprostane pathway, J. Biol. Chem., 283, 15533, 10.1074/jbc.R700047200 Morrow, 1990, A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism, Proc. Natl. Acad. Sci. USA., 87, 9383, 10.1073/pnas.87.23.9383 Kunapuli, 1997, Functional characterization of the ocular prostaglandin f2alpha (PGF2alpha) receptor. Activation by the isoprostane, 12-iso-PGF2alpha, J. Biol. Chem., 272, 27147, 10.1074/jbc.272.43.27147 Takahashi, 1992, Glomerular actions of a free radical-generated novel prostaglandin, 8-epi-prostaglandin F2 alpha, in the rat. Evidence for interaction with thromboxane A2 receptors, J. Clin. Invest., 90, 136, 10.1172/JCI115826 Guido, 1993, Quantitation of hydroperoxy-eicosatetraenoic acids and hydroxy-eicosatetraenoic acids as indicators of lipid peroxidation using gas chromatography-mass spectrometry, Anal. Biochem., 209, 123, 10.1006/abio.1993.1091 Shishehbor, 2006, Systemic elevations of free radical oxidation products of arachidonic acid are associated with angiographic evidence of coronary artery disease, Free Radic. Biol. Med., 41, 1678, 10.1016/j.freeradbiomed.2006.09.001 Tai, 2002, Prostaglandin catabolizing enzymes, Prostaglandins Other Lipid Mediat., 68–69, 483, 10.1016/S0090-6980(02)00050-3 Kumlin, 1986, Radioimmunoassay for 11-dehydro-TXB2: a method for monitoring thromboxane production in vivo, Prostaglandins., 32, 741, 10.1016/0090-6980(86)90196-6 Catella, 1986, 11-Dehydrothromboxane B2: a quantitative index of thromboxane A2 formation in the human circulation, Proc. Natl. Acad. Sci. USA., 83, 5861, 10.1073/pnas.83.16.5861 Westlund, 1994, 11-Hydroxythromboxane B2 dehydrogenase is identical to cytosolic aldehyde dehydrogenase, FEBS Lett., 345, 99, 10.1016/0014-5793(94)00409-9 Roberts, 1982, Metabolic fate of thromboxane A2 and prostacyclin, Adv. Prostaglandin Thromboxane Leukot. Res., 10, 211 Böhm, 2004, 11-Dehydro-thromboxane B2, a stable thromboxane metabolite, is a full agonist of chemoattractant receptor-homologous molecule expressed on TH2 cells (CRTH2) in human eosinophils and basophils, J. Biol. Chem., 279, 7663, 10.1074/jbc.M310270200 Ensor, 1995, 15-Hydroxyprostaglandin dehydrogenase, J. Lipid Mediat. Cell Signal., 12, 313, 10.1016/0929-7855(95)00040-W Cho, 2006, Role of glutamine 148 of human 15-hydroxyprostaglandin dehydrogenase in catalytic oxidation of prostaglandin E2, Bioorg. Med. Chem., 14, 6486, 10.1016/j.bmc.2006.06.030 Myung, 2006, 15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis, Proc. Natl. Acad. Sci. USA., 103, 12098, 10.1073/pnas.0603235103 Chou, 2007, Identification of a novel prostaglandin reductase reveals the involvement of prostaglandin E2 catabolism in regulation of peroxisome proliferator-activated receptor gamma activation, J. Biol. Chem., 282, 18162, 10.1074/jbc.M702289200 Yokomizo, 1996, cDNA cloning, expression, and mutagenesis study of leukotriene B4 12-hydroxydehydrogenase, J. Biol. Chem., 271, 2844, 10.1074/jbc.271.5.2844 Ensor, 1998, Purification, cDNA cloning and expression of 15-oxoprostaglandin 13-reductase from pig lung, Biochem. J., 330, 103, 10.1042/bj3300103 Clish, 2000, Oxidoreductases in lipoxin A4 metabolic inactivation: a novel role for 15-onoprostaglandin 13-reductase/leukotriene B4 12-hydroxydehydrogenase in inflammation, J. Biol. Chem., 275, 25372, 10.1074/jbc.M002863200 Gross, 2005, Levels of prostaglandin E metabolite, the major urinary metabolite of prostaglandin E2, are increased in smokers, Clin. Cancer Res., 11, 6087, 10.1158/1078-0432.CCR-05-0733 Hori, 2004, Structural basis of leukotriene B4 12-hydroxydehydrogenase/15-Oxo-prostaglandin 13-reductase catalytic mechanism and a possible Src homology 3 domain binding loop, J. Biol. Chem., 279, 22615, 10.1074/jbc.M312655200 Berry, 2003, Urinary metabolites of leukotriene B4 in the human subject, J. Biol. Chem., 278, 24449, 10.1074/jbc.M300856200 Diczfalusy, 1994, Beta-oxidation of eicosanoids, Prog. Lipid Res., 33, 403, 10.1016/0163-7827(94)90025-6 Wanders, 2006, Biochemistry of mammalian peroxisomes revisited, Annu. Rev. Biochem., 75, 295, 10.1146/annurev.biochem.74.082803.133329 Guilford, 2005, Second-generation beta-oxidation resistant 3-oxa-lipoxin A4 analogs, Prostaglandins Leukot. Essent. Fatty Acids., 73, 245, 10.1016/j.plefa.2005.05.012 Soberman, 1988, The identification and formation of 20-aldehyde leukotriene B4, J. Biol. Chem., 263, 7996, 10.1016/S0021-9258(18)68432-7 Sutyak, 1989, Identification of an aldehyde dehydrogenase in the microsomes of human polymorphonuclear leukocytes that metabolizes 20-aldehyde leukotriene B4, J. Biol. Chem., 264, 14818, 10.1016/S0021-9258(18)63773-1 Tukey, 2000, Human UDP-glucuronosyltransferases: metabolism, expression, and disease, Annu. Rev. Pharmacol. Toxicol., 40, 581, 10.1146/annurev.pharmtox.40.1.581 Turgeon, 2003, Glucuronidation of arachidonic and linoleic acid metabolites by human UDP-glucuronosyltransferases, J. Lipid Res., 44, 1182, 10.1194/jlr.M300010-JLR200 Newman, 2002, The simultaneous quantification of cytochrome P450 dependent linoleate and arachidonate metabolites in urine by HPLC-MS/MS, J. Lipid Res., 43, 1563, 10.1194/jlr.D200018-JLR200 Shui, 2008, Quantitative proteomic profiling of host-pathogen interactions: the macrophage response to mycobacterium tuberculosis lipids, J. Proteome Res., 8, 282, 10.1021/pr800422e Jenkins, 2006, Relative and absolute quantitative expression profiling of cytochromes P450 using isotope-coded affinity tags, Proteomics., 6, 1934, 10.1002/pmic.200500432 Clamp, 2004, The Jalview Java alignment, Bioinformatics, 20, 426, 10.1093/bioinformatics/btg430